Tuesday, Apr 30, 2019, 18:00 * Azrieli College for Engineering

with NURIT TWEEZER ZAKS M.D., Operating Partner, aMoon
& ALFIE YOUNG, Clinical Project Manager, PCI Clinical Services

A leading pharma investor and a top international pharma executive, as well as experienced Israeli entrepreneurs, are invited to share their insights about the challenges, and pitfalls to avoid, in the world of drug and pharmaceutical development. Bringing such high-level bio-professionals, experience, and knowledge will contribute to the optimal development of new pharma and biotech start-ups as well as new ideas. The Ying and Yang for success is the correct combination of smart funding and bio expertise.

The event is organized by JLM-BioCity (http://jlm-biocity.org/) and co-sponsored by The Azrieli College of Engineering (http://english.jce.ac.il/).

Participation is free but with RSVP.


18:00 Registrations
18:30 Greetings
Yaron Suissa – JLM-BioCity MODERATOR
Debbie Shalev – Head, Pharma Engineering, Azrieli College
Shlomo Farkas – GKH
18:40 Pharma start-ups Presentations
Betalin Therapeutics – Shay Herchcovici, CEO
Neurogenesis – Tal Gilat, CEO
Pelli Medica – Saul Yedgar, CEO
18:50 What Investors seek out in Pharma
Nurit Tweezer Zaks – aMoon
19:10 From Molecules to Markets
Alfie Young – PCI Clinical Services
19:30 Q&A

About NURIT TWEEZER ZAKS M.D., Operating Partner, aMoon:

Nurit brings to aMoon 12 years of experience with Sanofi, initially as Medical Director of Sanofi Israel and then as a Senior Director at Sanofi’s Global R&D arm for External Innovation & Scouting.

Nurit was also the Medical Lead at Sanofi for Global Established Products and Strategic Portfolio Enhancement. Prior to Sanofi, Nurit served over a decade as Senior Physician at Sheba Medical Center and Maccabi Health Services as a Specialist in Internal Medicine and Rheumatology, and as a Clinical and Research Fellow at the National Institutes of Health (NIH) in Maryland.

Nurit earned BSc and MD degrees at Ben Gurion University and a MBA at Kellogg Business School & the Tel Aviv University.

About ALFIE YOUNG, Clinical Project Manager, PCI Clinical Services:

Alfie joined PCI Pharma Services in November 2016 with a BSc in Clinical Sciences from the University of Bradford. As a member of the Project Management team at PCI Hay, Alfie has handled the responsibility of packaging IMP supplies for multiple sponsors of clinical trials taking place globally.

Alfie has been responsible for packaging over 30 different clinical protocols in this time, including large scale global phase 3 and 4 studies, and has developed a strong understanding of the themes of success in delivering IMP to clinical trials. As the primary contact for many of PCI’s global client base and internal departmental figures within PCI, Alfie is well positioned to advise and explain how every stakeholder in a clinical trial has their role to play in contributing to the successful delivery of a clinical trial at any phase and scale

About PCI Clinical Services www.pciservices.com
For further information: Dan Millard, Bus Dev Mgr
E: Dan.Millard@pciservices.com T: +44 7 824142823

PCI Clinical Services is an integrated full-service provider, a proven and trusted partner to leading companies in the global Clinical Trial industry. We offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful trial completion, delivering speed-to-market and success for our customers.

Our core services support each stage of the product lifecycle, including drug development, primary and secondary packaging, and labeling as well as global storage and distribution.